19
Views
20
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Oncogenic 70Z Cbl Mutation Blocks the Phosphotyrosine Binding Domain-Dependent Negative Regulation of ZAP-70 by c-Cbl in Jurkat T Cells

, &
Pages 6652-6664 | Received 04 Feb 1999, Accepted 25 Jun 1999, Published online: 28 Mar 2023

REFERENCES

  • Andoniou, C. E., C. B. Thien, and J. Langdon 1994. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 13:4515–4523.
  • Baulida, J., M. H. Kraus, M. Alimandi, P. P. Di Fiore, and J. Carpenter 1996. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271:5251–5257.
  • Blake, T. J., M. Shapiro, H. C. Morse, and J. Langdon 1991. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653–657.
  • Bonifacino, J. S., and J. Weissman 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Biol. 14:19–57.
  • Bonita, D. P., S. Miyake, M. L. Lupher Jr., W. Y. Langdon, and J. Band 1997. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl’s function and oncogenicity. Mol. Cell. Biol. 17:4597–4610.
  • Bonnerot, C., V. Briken, V. Brachet, D. Lankar, S. Cassard, B. Jabri, and J. Amigorena 1998. syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes. EMBO J. 17:4606–4616.
  • Borden, K. L., and J. Freemont 1996. The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6:395–401.
  • Chan, A. C., M. Dalton, R. Johnson, G. H. Kong, T. Wang, R. Thoma, and J. Kurosaki 1995. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 14:2499–2508.
  • Crowley, M. T., P. S. Costello, C. J. Fitzer-Attas, M. Turner, F. Meng, C. Lowell, V. L. Tybulewicz, and J. DeFranco 1997. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J. Exp. Med. 186:1027–1039.
  • D’Oro, U., K. Sakaguchi, E. Appella, and J. Ashwell 1996. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol. Cell. Biol. 16:4996–5003.
  • D’Oro, U., M. S. Vacchio, A. M. Weissman, and J. Ashwell 1997. Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. Immunity 7:619–628.
  • Deckert, M., C. Elly, A. Altman, and J. Liu 1998. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J. Biol. Chem. 273:8867–8874.
  • Donovan, J. A., Y. Ota, W. Y. Langdon, and J. Samelson 1996. Regulation of the association of p120cbl with Grb2 in Jurkat T cells. J. Biol. Chem. 271:26369–26374.
  • Donovan, J. A., R. L. Wange, W. Y. Langdon, and J. Samelson 1994. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem. 269:22921–22924.
  • Feshchenko, E. A., W. Y. Langdon, and J. Tsygankov 1998. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 273:8323–8331.
  • Gauen, L. K., Y. Zhu, F. Letourneur, Q. Hu, J. B. Bolen, L. A. Matis, R. D. Klausner, and J. Shaw 1994. Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol. Cell. Biol. 14:3729–3741.
  • Graus-Porta, D., R. R. Beerli, J. M. Daly, and J. Hynes 1997. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16:1647–1655.
  • Hicke, L. 1999. Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB J. 11:1215–1226.
  • Hime, G. R., M. P. Dhungat, A. Ng, and J. Bowtell 1997. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites. Oncogene 14:2709–2719.
  • Iwashima, M., B. A. Irving, N. S. van Oers, A. C. Chan, and J. Weiss 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263:1136–1139.
  • Keane, M. M., O. M. Rivero-Lezcano, J. A. Mitchell, K. C. Robbins, and J. Lipkowitz 1995. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 10:2367–2377.
  • Keshvara, L. M., C. Isaacson, T. M. Yankee, R. Sarac, M. L. Harrison, and J. Geahlen 1998. Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J. Immunol. 161:5276–5283.
  • Kiefer, F., J. Brumell, N. Al-Alawi, S. Latour, A. Cheng, A. Veillette, S. Grinstein, and J. Pawson 1998. The Syk protein tyrosine kinase is essential for Fcγ receptor signalling in macrophages and neutrophils. Mol. Cell. Biol. 18:4209–4220.
  • Kong, G., M. Dalton, J. B. Wardenburg, D. Straus, T. Kurosaki, and J. Chan 1996. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol. Cell. Biol. 16:5026–5035.
  • Lauritsen, J. P., M. D. Christensen, J. Dietrich, J. Kastrup, N. Odum, and J. Geisler 1998. Two distinct pathways exist for down-regulation of the TCR. J. Immunol. 161:260–267.
  • Lenferink, A. E., R. Pinkas-Kramarski, M. L. van de Poll, M. J. van Vugt, L. N. Klapper, E. Tzahar, H. Waterman, M. Sela, E. J. van Zoelen, and J. Yarden 1998. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 17:3385–3397.
  • Levkowitz, G., L. N. Klapper, E. Tzahar, A. Freywald, M. Sela, and J. Yarden 1996. Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene 12:1117–1125.
  • Levkowitz, G., H. Waterman, E. Zamir, Z. Kam, S. Oved, W. Y. Langdon, L. Beguinot, B. Geiger, and J. Yarden 1998. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:3663–3674.
  • Liu, Y. C., C. Elly, W. Y. Langdon, and J. Altman 1997. Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J. Biol. Chem. 272:168–173.
  • Lupher, M. L. Jr., N. Rao, N. L. Lill, C. E. Andoniou, S. Miyake, E. A. Clark, B. Druker, and J. Band 1998. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J. Biol. Chem. 273:35273–35281.
  • Lupher, M. L. Jr., K. A. Reedquist, S. Miyake, W. Y. Langdon, and J. Band 1996. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J. Biol. Chem. 271:24063–24068.
  • Lupher, M. L. Jr., Z. Songyang, S. E. Shoelson, L. C. Cantley, and J. Band 1997. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J. Biol. Chem. 272:33140–33144.
  • Luton, F., V. Legendre, J. P. Gorvel, A. M. Schmitt-Verhulst, and J. Boyer 1997. Tyrosine and serine protein kinase activities associated with ligand-induced internalized TCR/CD3 complexes. J. Immunol. 158:3140–3147.
  • McVicar, D. W., L. S. Taylor, P. Gosselin, J. Willette-Brown, A. I. Mikhael, R. L. Geahlen, M. C. Nakamura, P. Linnemeyer, W. E. Seaman, S. K. Anderson, J. R. Ortaldo, and J. Mason 1998. DAP12-mediated signal transduction in natural killer cells. A dominant role for the syk protein-tyrosine kinase. J. Biol. Chem. 273:32934–32942.
  • Meisner, H., A. Daga, J. Buxton, B. Fernandez, A. Chawla, U. Banerjee, and J. Czech 1997. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol. 17:2217–2225.
  • Meng, W., S. Sawasdikosol, S. J. Burakoff, and J. Eck 1999. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398:84–90.
  • Miyake, S., M. L. Lupher Jr., B. Druker, and J. Band 1998. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. Proc. Natl. Acad. Sci. USA 95:7927–7932.
  • Murphy, M. A., R. G. Schnall, D. J. Venter, L. Barnett, I. Bertoncello, C. B. Thien, W. Y. Langdon, and J. Bowtell 1998. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell. Biol. 18:4872–4882.
  • Naramura, M., H. K. Kole, R.-J. Hu, and J. Gu 1998. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA 95:15547–15552.
  • Northrop, J. P., M. J. Pustelnik, A. T. Lu, and J. Grove 1996. Characterization of the roles of SH2 domain-containing proteins in T-lymphocyte activation by using dominant negative SH2 domains. Mol. Cell. Biol. 16:2255–2263.
  • Ojaniemi, M., W. Y. Langdon, and J. Vuori 1998. Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation. Oncogene 16:3159–3167.
  • Ollendorff, V., M. Mattei, E. Fournier, J. Adelaide, M. Lopez, O. Rosnet, and J. Birnbaum 1998. A third human CBL gene is on chromosome 19. Int. J. Oncol. 13:1159–1161.
  • Ota, Y., L. O. Beitz, A. M. Scharenberg, J. A. Donovan, J. P. Kinet, and J. Samelson 1996. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med. 184:1713–1723.
  • Ota, Y., and J. Samelson 1997. The product of the proto-oncogene c-Cbl: a negative regulator of the Syk tyrosine kinase. Science 276:418–420.
  • Peterson, E. J., J. L. Clements, N. Fang, and J. Koretzky 1998. Adaptor proteins in lymphocyte antigen-receptor signaling. Curr. Opin. Immunol. 10:337–344.
  • Pizon, V., M. Desjardins, C. Bucci, R. G. Parton, and J. Zerial 1994. Association of Rap1a and Rap1b proteins with late endocytic/phagocytic compartments and Rap2a with the Golgi complex. J. Cell Sci. 107:1661–1670.
  • Poole, A., J. M. Gibbins, M. Turner, M. J. van Vugt, J. G. J. van de Winkel, T. Saito, V. L. Tybulewicz, and J. Watson 1997. The Fc-receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 16:2333–2341.
  • Qian, D., M. N. Mollenauer, and J. Weiss 1996. Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. J. Exp. Med. 183:611–620.
  • Rao, A., C. Luo, and J. Hogan 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707–747.
  • Rellahan, B. L., L. J. Graham, B. Stoica, K. E. DeBell, and J. Bonvini 1997. Cbl-mediated regulation of T cell receptor-induced AP1 activation. Implications for activation via the Ras signaling pathway. J. Biol. Chem. 272:30806–30811.
  • Secrist, J. P., L. A. Burns, L. Karnitz, G. A. Koretzky, and J. Abraham 1993. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268:5886–5893.
  • Shpetner, H., M. Joly, D. Hartley, and J. Corvera 1996. Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J. Cell Biol. 132:595–605.
  • Smit, L., and J. Borst 1998. The Cbl family of signal transduction molecules. Crit. Rev. Oncogenesis 8:359–379.
  • Soede, R. D. M., Y. M. Wijnands, I. Van Kouteren-Cobzaru, and J. Roos 1998. ZAP-70 tyrosine kinase is required for LFA-1-dependent T cell migration. J. Cell Biol. 142:1371–1379.
  • Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider et al.. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767–778.
  • Sorkin, A. 1998. Endocytosis and intracellular sorting of receptor tyrosine kinases. Front. Biosci. 3:729–738.
  • Spencer, D. M., T. J. Wandless, S. L. Schreiber, and J. Crabtree 1993. Controlling signal transduction with synthetic ligands. Science 262:1019–1024.
  • Takata, M., H. Sabe, A. Hata, T. Inazu, Y. Homma, T. Nukada, H. Yamamura, and J. Kurosaki 1994. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J. 13:1341–1349.
  • Thien, C. B., and J. Langdon 1997. EGF receptor binding and transformation by v-Cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans Sli-1 gene. Oncogene 14:2239–2249.
  • Thien, C. B., and J. Langdon 1997. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene 15:2909–2919.
  • Tybulewicz, V. L. 1998. Analysis of antigen receptor signalling using mouse gene targeting. Curr. Opin. Cell Biol. 10:195–204.
  • Ueno, H., K. Sasaki, K. Miyagawa, H. Honda, K. Mitani, Y. Yazaki, and J. Hirai 1997. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem. 272:8739–8743.
  • van Leeuwen, J. E. M., P. K. Paik, and J. Samelson 1999. Activation of NFAT and AP1 by oncogenic 70Z Cbl requires an intact PTB domain but not Crk(L) or p85 PI3K association. J. Biol. Chem. 274:5153–5162.
  • van Leeuwen, J. E. M., and J. Samelson 1999. T cell antigen-receptor signal transduction. Curr. Opin. Immunol. 11:242–248.
  • van Leeuwen, J. E. M., and L. E. Samelson. Unpublished data.
  • Wang, Y., Y. G. Yeung, W. Y. Langdon, and J. Stanley 1996. c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 271:17–20.
  • Wang, Y., Y. G. Yeung, and J. Stanley 1999. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J. Cell. Biochem. 72:119–134.
  • Wange, R. L., R. Guitian, N. Isakov, J. D. Watts, R. Aebersold, and J. Samelson 1995. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 270:18730–18733.
  • Williams, B. L., K. L. Schreiber, W. Zhang, R. L. Wange, L. E. Samelson, P. J. Leibson, and J. Abraham 1998. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18:1388–1399.
  • Yoon, C. H., J. Lee, G. D. Jongeward, and J. Sternberg 1995. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269:1102–1105.
  • Zhang, Z., C. Elly, A. Altman, and J. Liu 1999. Dual regulation of T cell receptor-mediated signaling by oncogenic Cbl mutant 70Z. J. Biol. Chem. 274:4883–4889.
  • Zhao, Q., and J. Weiss 1996. Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70. Mol. Cell. Biol. 16:6765–6774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.